Drug Shortage Report for FRAXIPARINE

Last updated on 2020-05-19 History
Report ID 111066
Drug Identification Number 02450631
Brand name FRAXIPARINE
Common or Proper name FRAXIPARINE 0.6ml 10SPR 5700 IU
Company Name ASPEN PHARMACARE CANADA INC.
Market Status DORMANT
Active Ingredient(s) NADROPARIN CALCIUM
Strength(s) 9500UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-04-06
Estimated end date 2020-05-07
Actual end date 2020-05-07
Shortage status Resolved
Updated date 2020-05-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2030 BRISTOL CIRCLE, SUITE 201
OAKVILLE, ONTARIO
CANADA L6H 0H2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2020-05-19 French Compare
v14 2020-05-19 English Compare
v13 2020-05-13 French Compare
v12 2020-05-13 English Compare
v11 2020-05-08 French Compare
v10 2020-05-08 English Compare
v9 2020-05-04 French Compare
v8 2020-05-04 English Compare
v7 2020-04-29 French Compare
v6 2020-04-29 English Compare
v5 2020-04-23 French Compare
v4 2020-04-23 English Compare
v3 2020-04-07 English Compare
v2 2020-04-06 French Compare
v1 2020-04-06 English Compare

Showing 1 to 15 of 15